An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif | Science Immunology
Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses | Science Immunology
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant - ScienceDirect
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail | Nature Microbiology
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern | Science Translational Medicine
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant | Clinical Microbiology Reviews
Structure and Mutations of SARS-CoV-2 Spike Protein: A Focused Overview | ACS Infectious Diseases
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination - ScienceDirect
Fast Prediction of Binding Affinities of SARS-CoV-2 Spike Protein and Its Mutants with Antibodies through Intermolecular Interaction Modeling-Based Machine Learning | The Journal of Physical Chemistry B
Predictive profiling of SARS-CoV-2 variants by deep mutational learning | bioRxiv
An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif | Science Immunology
SARS‐CoV‐2 variants and spike mutations involved in second wave of COVID‐19 pandemic in India - Muttineni - 2022 - Transboundary and Emerging Diseases - Wiley Online Library
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice | Science Translational Medicine
Predictive profiling of SARS-CoV-2 variants by deep mutational learning | bioRxiv
Investigation of target sequencing of SARS-CoV-2 and immunogenic GWAS profiling in host cells of COVID-19 in Vietnam | BMC Infectious Diseases | Full Text
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite - ScienceDirect
An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif | Science Immunology
COVID-19 Antibody Tests and Their Limitations | ACS Sensors
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail | Nature Microbiology
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail | Nature Microbiology
Omicron BA.2 (B.1.1.529.2): High Potential for Becoming the Next Dominant Variant | The Journal of Physical Chemistry Letters
Differential patterns of cross-reactive antibody response against SARS-CoV-2 spike protein detected for chronically ill and healthy COVID-19 naïve individuals | Scientific Reports
Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization - ScienceDirect
Fast Prediction of Binding Affinities of SARS-CoV-2 Spike Protein and Its Mutants with Antibodies through Intermolecular Interaction Modeling-Based Machine Learning | The Journal of Physical Chemistry B
Predictive profiling of SARS-CoV-2 variants by deep mutational learning | bioRxiv
